Zobrazeno 1 - 10
of 301
pro vyhledávání: '"chronic neutropenia"'
Autor:
Lilian Roland, Chi Huu Nguyen, Katarina Zmajkovicova, Mélanie Khamyath, Maria Kalogeraki, Bérénice Schell, Vanessa Gourhand, Vincent Rondeau, Zeina Abou Nader, Halenya Monticelli, Barbara Maierhofer, Robert Johnson, Arthur Taveras, Marion Espéli, Karl Balabanian
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundWHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome is an ultra-rare, combined primary immunodeficiency and chronic neutropenic disorder characterized by a range of clinical presentations, including peripheral neutro
Externí odkaz:
https://doaj.org/article/0dce767235e54235a04e512a4f02e6e0
Autor:
Letícia Matushita, Elvis Terci Valera, Davi Casale Aragon, Carlos Alberto Scridelli, Persio Roxo-Junior, Luciana Martins de Carvalho
Publikováno v:
Jornal de Pediatria, Vol 100, Iss 3, Pp 311-317 (2024)
Objective: To assess the prevalence of chronic neutropenia (CN) and the clinical profile of patients with CN aged up to 18 years, followed in the pediatric hematology, rheumatology, or immunology outpatient clinic of a tertiary medical center from Ma
Externí odkaz:
https://doaj.org/article/1e1970aa7b144be5a97e27e04aba43c8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Curr Opin Hematol
PURPOSE OF THE REVIEW: Registries provide “real world” perspectives on the natural history and outcomes for many clinical conditions. The purpose of this review is to identify registries for non-malignant hematological disease and to describe the
Objectives To describe the clinical characteristics of patients with chronic neutropenia. Methods Data of 36 patients with chronic neutropenia, who were followed up in the authors' clinic between May 2013 and May 2020, were analyzed retrospectively.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d792e5a07ef94e3b76abf0daedb17f48
https://hdl.handle.net/20.500.12511/9970
https://hdl.handle.net/20.500.12511/9970
Autor:
Omer Kartal, Hatice Mine Cakmak
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S24-(2021)
Objective: Immun-component children with moderate neutropenia do not have an increased risk for severe bacterial infections. However, there is limited data for the management of benign neutropenia in children. Therefore, we aimed to determine the mos
Autor:
Farhoodi A, Ahangari Gh, Chavoshzadeh Z, Ramyar A, Movahedi M, Ghareghozlou M, Fazlolahi M, Heydarzadeh M, Bemanian M H, Mansori M, Zandieh F
Publikováno v:
Tehran University Medical Journal, Vol 65, Iss 7, Pp 1-10 (2007)
Background: Mutations of ELA2, the gene encoding neutrophil elastase (NE) are known to be associated with cyclic neutropenia (CN) and severe congenital neutropenia (SCN). However, high variability of these mutations has been reported. This study was
Externí odkaz:
https://doaj.org/article/eb7dc16dcc2949c8979bc066038fa80a
Publikováno v:
ecancermedicalscience
Thinggaard, A B, Liposits, G & Fristrup, N 2020, ' Dealing with pre-existing chronic neutropenia in cancer patients—considerations and consequences in the clinical praxis ', ecancermedicalscience, vol. 14, 1131 . https://doi.org/10.3332/ECANCER.2020.1131
Thinggaard, A B, Liposits, G & Fristrup, N 2020, ' Dealing with pre-existing chronic neutropenia in cancer patients—considerations and consequences in the clinical praxis ', ecancermedicalscience, vol. 14, 1131 . https://doi.org/10.3332/ECANCER.2020.1131
Chronic neutropenia is a rare but important challenge with substantial clinical implications for patients receiving antineoplastic treatment. Treatment-induced neutropenia is a well-known adverse event during chemotherapy and some targeted treatments